Cargando…

Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia

BACKGROUND: Febrile neutropenia (FNP) causes significant morbidity and mortality in children undergoing treatment for cancer. The development of clinical decision rules to help stratify risks in paediatric FNP patients and the use of inflammatory biomarkers to identify high risk patients is an area...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hemming, Victoria, Jakes, Adam D., Shenton, Geoff, Phillips, Bob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217195/ https://www.ncbi.nlm.nih.gov/pubmed/28056911 http://dx.doi.org/10.1186/s12887-016-0766-8

Ejemplares similares

Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia
por: Doerflinger, Marcel, et al.
Publicado: (2021)

PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study
por: Morgan, Jessica Elizabeth, et al.
Publicado: (2022)

Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children
por: Morgan, Jessica E, et al.
Publicado: (2021)

The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients
por: Moustafa, Rania, et al.
Publicado: (2021)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Serum Endocan Levels in Children with Febrile Neutropenia
por: Kiral, Eylem, et al.
Publicado: (2016)

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: Haddad, Hanine El, et al.
Publicado: (2018)

Clinicohematological Profile of Febrile Neutropenia in Childhood Acute Leukemia and Utility of Serum Procalcitonin Levels in Neutropenic Patients
por: Kapoor, Rajan, et al.
Publicado: (2018)

Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department
por: García de Guadiana-Romualdo, Luis, et al.
Publicado: (2018)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia
por: Phillips, Bob
Publicado: (2022)

Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study
por: Işlak Mutcal, Sibel, et al.
Publicado: (2016)

Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia
por: Meidani, Mohsen, et al.
Publicado: (2013)

The Usefulness of Procalcitonin and C-Reactive Protein as Early Diagnostic Markers of Bacteremia in Cancer Patients with Febrile Neutropenia
por: Kim, Dae Yong, et al.
Publicado: (2011)

Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: El Haddad, Hanine, et al.
Publicado: (2018)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Individual participant data validation of the PICNICC prediction model for febrile neutropenia
por: Phillips, Bob, et al.
Publicado: (2020)

Monitoring Procalcitonin in Febrile Neutropenia: What Is Its Utility for Initial Diagnosis of Infection and Reassessment in Persistent Fever?
por: Robinson, James Owen, et al.
Publicado: (2011)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Risk factors for bacteremia in children with febrile neutropenia
por: KARA, Soner Sertan, et al.
Publicado: (2019)

1550. Pediatric Febrile Neutropenia: Does Depth and Duration of Neutropenia at Presentation Predict Outcomes?
por: Alali, Muayad, et al.
Publicado: (2018)

SARS-CoV-2 infection in children with febrile neutropenia
por: Flores, Victoria, et al.
Publicado: (2020)

Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia
por: Haeusler, Gabrielle M, et al.
Publicado: (2020)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

The role of procalcitonin in febrile patients
por: Hatipoglu, Mustafa, et al.
Publicado: (2015)

Use of biomarkers in the management of febrile neutropenia episodes in children with cancer()
por: de Oliveira, Benigna Maria
Publicado: (2016)

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis
por: Mahtani, Reshma L., et al.
Publicado: (2022)

Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal
por: Shilpakar, Ramila, et al.
Publicado: (2019)

Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia
por: Morgan, Jessica E, et al.
Publicado: (2014)

Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules
por: Haeusler, Gabrielle M., et al.
Publicado: (2020)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia
por: Stoma, Igor, et al.
Publicado: (2019)

Aminoglycoside use in paediatric febrile neutropenia – Outcomes from a nationwide prospective cohort study
por: McMullan, Brendan J., et al.
Publicado: (2020)

Effectiveness of a conservation energy model for febrile neutropenia in children with cancer
por: Khoirunnisa, Khoirunnisa, et al.
Publicado: (2020)

Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study
por: Söderman, Martina, et al.
Publicado: (2016)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ntg3a6i0qn37m5vdnnqve3au9g